Your browser doesn't support javascript.
loading
Vaccine provision: Delivering sustained & widespread use.
Preiss, Scott; Garçon, Nathalie; Cunningham, Anthony L; Strugnell, Richard; Friedland, Leonard R.
Affiliation
  • Preiss S; GSK Vaccines, 20 Avenue Fleming, Parc de la Noire Epine, B-1300 Wavre, Belgium. Electronic address: scott.s.preiss@gsk.com.
  • Garçon N; BIOASTER, 40 Avenue Tony Garnier, 69007 Lyon, France. Electronic address: nathalie.garcon@bioaster.org.
  • Cunningham AL; Westmead Institute, the Centre for Virus Research, 176 Hawkesbury Road, NSW 2145, Australia. Electronic address: tony.cunningham@sydney.edu.au.
  • Strugnell R; Department of Microbiology and Immunology, University of Melbourne, Doherty Institute, Parkville, Victoria 3010, Australia. Electronic address: rastru@unimelb.edu.au.
  • Friedland LR; GSK Vaccines, 5 Crescent Drive, Philadelphia, PA, United States. Electronic address: leonard.r.friedland@gsk.com.
Vaccine ; 34(52): 6665-6671, 2016 12 20.
Article in En | MEDLINE | ID: mdl-27884478
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Clinical Trials as Topic / Technology, Pharmaceutical / Drug Approval / Drug Evaluation, Preclinical / Drug Discovery Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Vaccine Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Clinical Trials as Topic / Technology, Pharmaceutical / Drug Approval / Drug Evaluation, Preclinical / Drug Discovery Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Vaccine Year: 2016 Document type: Article